Pazeo and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Pazeo (olopatadine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dupixent, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Rashes when taking Pazeo. It is created by eHealthMe based on reports of 1,252 people who have side effects when taking Pazeo from the FDA, and is updated regularly.

What is Pazeo?

Pazeo has active ingredients of olopatadine hydrochloride. eHealthMe is studying from 1,256 Pazeo users. Check the latest studies of Pazeo.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.

On Apr, 26, 2026

1,252 people reported to have side effects when taking Pazeo.
Among them, 57 people (4.55%) have Rashes.

Among these 57 people:

How long have people been on Pazeo when they have Rashes? *

What is the gender of people who have Rashes when taking Pazeo? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Rashes when taking Pazeo? *

What are other drugs people take besides Pazeo? *

Dupixent: 17 people, 29.82%
Lidocaine: 9 people, 15.79%
Epinephrine: 9 people, 15.79%
Diphenhydramine Hydrochloride: 9 people, 15.79%
Acetaminophen: 9 people, 15.79%
Nystatin: 8 people, 14.04%
Albuterol Sulfate: 8 people, 14.04%
Restasis: 8 people, 14.04%
Adderall: 7 people, 12.28%
Lidoderm: 7 people, 12.28%

What are other side effects people have besides Rashes? *

Head Injury: 9 people, 15.79%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 14.04%
Fatigue (feeling of tiredness): 8 people, 14.04%
Fall: 8 people, 14.04%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 8 people, 14.04%
Diarrhea: 8 people, 14.04%
Discomfort: 8 people, 14.04%
Headache (pain in head): 7 people, 12.28%
Eye Irritation: 6 people, 10.53%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 6 people, 10.53%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 13 people, 22.81%
Primary Myelofibrosis (primary disorder of the bone marrow): 6 people, 10.53%
Asthma: 5 people, 8.77%
Multiple Myeloma (cancer of the plasma cells): 4 people, 7.02%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 4 people, 7.02%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 7.02%
Pemphigoid (tense blisters on the skin): 4 people, 7.02%
High Blood Pressure: 3 people, 5.26%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.26%
Osteoporosis (bones weak and more likely to break): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pazeo and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pazeo:

Pazeo (1,256 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Pazeo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride (the active ingredients of Pazeo) and Pazeo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.